Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patient Focus Could Shield PCORI From Controversy When Findings Contradict Accepted Standards

Executive Summary

Having patients involved in all facets of the research process could help protect the Patient-Centered Outcomes Research Institute from controversy should research findings contradict generally accepted standards of care, speakers at a comparative effectiveness summit said.

You may also be interested in...



Methods Research Dominates PCORI Pilot Projects

The Patient-Centered Outcomes Research Institute announced the awardees of pilot project research funds, with many winners emphasizing research that advances the methodology of conducting patient-centered outcomes research.

PCORI Grant Process Begins, But Challenge Of Involving Nontraditional Researchers Remains

The Patient-Centered Outcomes Research Institute approved its priorities and research agenda May 21, and revealed funding amounts for clinical comparative research the following day. But, as the board of governors’ discussion showed, one of PCORI’s biggest challenges remains how to bring in nontraditional researchers to help give its research a uniquely patient-centered focus.

PCORI Will Ask Research Funding Applicants To Include Ideas For Disseminating Results – Draft Plan

Draft checklist would ask researchers for ideas on involving stakeholders, “engagement points,” and ways to disseminate research results, indicating PCORI will ask researchers to think outside of their typical approaches such as journal publication or scientific meetings.

Related Content

Topics

UsernamePublicRestriction

Register

LL1134531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel